Nova R Wealth Inc. decreased its stake in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 2.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 332,969 shares of the company’s stock after selling 6,863 shares during the quarter. BlackRock Health Sciences Trust accounts for about 6.9% of Nova R Wealth Inc.’s investment portfolio, making the stock its 3rd biggest position. Nova R Wealth Inc.’s holdings in BlackRock Health Sciences Trust were worth $13,961,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently made changes to their positions in BME. Logan Stone Capital LLC acquired a new position in BlackRock Health Sciences Trust in the second quarter valued at about $600,000. City of London Investment Management Co. Ltd. acquired a new position in shares of BlackRock Health Sciences Trust during the second quarter worth approximately $429,000. Wolverine Asset Management LLC lifted its position in shares of BlackRock Health Sciences Trust by 360.1% during the second quarter. Wolverine Asset Management LLC now owns 60,108 shares of the company’s stock worth $2,455,000 after purchasing an additional 47,044 shares in the last quarter. Consolidated Portfolio Review Corp lifted its position in shares of BlackRock Health Sciences Trust by 133.8% during the second quarter. Consolidated Portfolio Review Corp now owns 39,721 shares of the company’s stock worth $1,623,000 after purchasing an additional 22,729 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its position in shares of BlackRock Health Sciences Trust by 4.3% during the second quarter. Cambridge Investment Research Advisors Inc. now owns 54,605 shares of the company’s stock worth $2,231,000 after purchasing an additional 2,240 shares in the last quarter.
BlackRock Health Sciences Trust Price Performance
Shares of BME stock traded down $0.48 during trading hours on Tuesday, reaching $41.78. 9,948 shares of the company were exchanged, compared to its average volume of 31,518. The stock’s fifty day moving average is $41.75 and its two-hundred day moving average is $40.74. BlackRock Health Sciences Trust has a fifty-two week low of $35.53 and a fifty-two week high of $42.86.
BlackRock Health Sciences Trust Dividend Announcement
BlackRock Health Sciences Trust Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Featured Stories
- Five stocks we like better than BlackRock Health Sciences Trust
- Bank Stocks – Best Bank Stocks to Invest In
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- The How and Why of Investing in Gold Stocks
- AMD Gains Momentum With AI: Can It Beat Expectations?
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.